1 / 83

Philippines Dialysis Market Analysis Sample Report

This report presents a strategic analysis of the Philippines Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com

Insights4
Download Presentation

Philippines Dialysis Market Analysis Sample Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on Philippines Dialysis Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the Philippines Dialysis Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, types of clinical diagnostics, point-of-care testing, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Philippines Dialysis Market, and offers unmatched value, accuracy, and expert insights

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 12-25 1. Dialysis Overview 1.1. Overview 1.2. Philippines Overview 1.3. Economic Overview: Philippines 1.4. Dialysis Market in Philippines 1.5. Pharmaceuticals Market in Philippines 1.6. Healthcare Scenario in Philippines 1.7. Health Insurance Coverage: Philippines 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-33 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. Type 2.2.2. Product & Services 2.2.3. End User 34-38 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Philippines Dialysis Market Driver 1 3.1.2. Philippines Dialysis Market Driver 2 3.1.3. Philippines Dialysis Market Driver 3 3.2. Market Restraints 3.2.1. Philippines Dialysis Market Restraint 1 3.2.2. Philippines Dialysis Market Restraint 2 5 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  6. Table of Content CONTENT PG. NO. 3.2.3. Philippines Dialysis Market Restraint 3 39-49 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. Fresenius Medical Care 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. B. Braun Melsungen 4.2.2.1. Overview 6 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  7. Table of Content CONTENT PG. NO. 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. DaVita 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. Baxter Healthcare 4.2.4.1. Overview 7 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  8. Table of Content CONTENT PG. NO. 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Asahi Kasei Corporation 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. Nipro 4.2.6.1. Overview 8 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  9. Table of Content CONTENT PG. NO. 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Nikkiso Medical Systems 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. Angiodynamics 4.2.8.1. Overview 9 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  10. Table of Content CONTENT PG. NO. 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. Hemotek Renal Center 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. Nephro Group Dialysis Center 4.2.10.1. Overview 10 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  11. Table of Content CONTENT PG. NO. 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 50-57 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 58-63 6. Methodology & Scope 11 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  12. Philippines Dialysis Market Analysis 1. Dialysis Overview

  13. 1.1 Statistics at a Glance: The Scenario of Dialysis in the World Scope of Dialysis Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 850 Mn worldwide suffer from some kind of kidney disease 10.4% is the prevalence of chronic kidney disease among men In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 11.8% is the prevalence of chronic kidney disease among women 5.3-10.5 Mn people require dialysis or transplantation In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 90% succumb to death due to the lack of access and unaffordability of dialysis $88,195 is the average cost per patient for dialysis is the US 13 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  14. 1.1 Statistics at a Glance: The Scenario of Dialysis in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Africa Egypt Market ~$XX Mn Market ~Market Size of $XX Bn Illustrative Illustrative 14 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  15. 1.2 Philippines Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 111 Mn Is the population of Philippines, in 2021 $394 Mn Is the Gross Domestic Product (GDP) in Philippines in 2021 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 30 Is the median age in Philippines, in 2022 $175 per capita was the amount of national health expenditures in 2021 15 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  16. 1.3 Economic Overview: Philippines Population of Philippines, (2020-2030) GDP of Philippines, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  17. 1.4 Statistics at a Glance: The Scenario of Dialysis in Philippines Scope of Dialysis Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 2.3 Mn Filipinos suffer from chronic kidney disease 8.5% of deaths in the Philippines occur due to kidney disease In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Philippines ▪ 400% dialysis prevalence has increases in the past decade 3rd Davao city in Philippines ranks third with the most kidney diseases In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ $36 Mn has been spent by PhilHealth on patients with dialysis during the pandemic Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 17 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  18. 1.5 Pharmaceuticals in Philippines Philippines Pharmaceuticals Market Forecast, 2022-2030 (in $Bn) XX 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Pharmaceuticals market in Philippines, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  19. 1.6 Healthcare Scenario in Philippines Dialysis Drug Development Process: The process of developing a Dialysis drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the Dialysis drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating Dialysis Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  20. 1.6 Healthcare Scenario: Kidney Disease Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke Initial Diagnosis Imaging (confirm bone related changes or respiratory problems) A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: Genetic testing (detect the type of SCD) • Stroke: Chronic transfusions, HU Stakeholders PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist Depending on the organ complications, the treatment involves different specialists at different times Illustrative Illustrative 20 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  21. 1.7 Health Insurance Coverage: Philippines % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 21 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  22. 1.8 Budget of Philippines Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% oftotal NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  23. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend XX XX 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  24. 1.9 Mergers and Acquisitions (continued) Latest Deals In Philippines Amount / Duration Company Name Type Year Key Pointers Oracle’s acquisition of Cerner is big tech’s latest foray into the healthcare system, promising better outcomes Oracle acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 Bn in equity value Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities ▪ ▪ Acquisition $28.3 Bn June, 2022 ▪ Oracle acquisition of Cerner GSK has acquire BELLUS for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion ▪ BELLUS is a late-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough ▪ Acquisition $2 Bn April 2023 Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough ▪ GSK acquisition of BELLUS Health Illustrative Illustrative 24 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  25. 1.9 Mergers and Acquisitions (continued) Latest Deals In Philippines Amount / Duration Company Name Type Year Key Pointers Merger March 2023 Merger Jan 2023 25 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  26. Philippines Dialysis Market Analysis 2. Market Size and Forecasting

  27. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Philippines Dialysis Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Philippines Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Philippines Market Size (Bn $) 61 74 84 87 91 95 99 106 27 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  28. 2.2 Snapshot of Dialysis Market Segmentation Type Product & Services End User Hemodialysis Equipment In-center dialysis Peritoneal dialysis Consumables Home dialysis Dialysis Drugs Services In this section you will get an understanding of the segmentations which will cover the Philippines Dialysis Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 28 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  29. 2.2.1 Market Segmentation: By Type Philippines Dialysis Market Share, By Type (2022) Hemodialysis market in Philippines is a significant component of the overall dialysis treatment market ▪ It has the maximum market share in Philippines dialysis market with approximately xx% ▪ Peritoneal dialysis, 20% Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Hemodialysis, 43% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 29 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  30. 2.2.2 Market Segmentation: By Product & Services Philippines Dialysis Market Share, By Product & Services (2022) Equipment market in Philippines is a significant component of the overall dialysis market ▪ Services It has the maximum market share in Philippines dialysis market with approximately xx% ▪ Equipment Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Dialysis Drugs In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Consumables 30 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  31. 2.2.3 Market Segmentation: By End User Philippines Dialysis Market Share, By End User (2022) In-center dialysis have the maximum market share in Philippines dialysis market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Home dialysis In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ In-center dialysis 31 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  32. Philippines Dialysis Market Analysis 3. Market Dynamics

  33. 3.1 Market growth drivers 3.1.1 The Philippine Health Insurance Corporation (PhilHealth) will increase its outpatient hemodialysis coverage in 2023 from 90 to 156 sessions PhilHealth pays a considerable amount of qualifying patients' dialysis treatment costs ▪ Coverage of PhilHealth This is driving the demand for dialysis treatments and creating opportunities for growth in the dialysis market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 33 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  34. 3.1 Market growth drivers (continued) 3.1.2 Philippines has seen a 400% growth in the prevalence of dialysis during the last ten years Top countries that are leveraging technology in their fight against Dialysis Kidney failure (including early stages of CKD) has become a prominent cause of hospitalization and the tenth greatest cause of death in the Philippines ▪ Norway IT has a robust healthcare infrastructure, including world- renowned research institutions, hospitals, and clinics, that are dedicated to dialysis treatment and research ▪ Austria Denmark Belgium Spain One of the key factors that has allowed Philippines to stay ahead in the field of dialysis research and treatment is the high level of investment in dialysis-related research ▪ Italy Netherlands Sweden Singapore Switzerland In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Israel Australia Canada Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ France United Kingdom China South Korea Germany Japan United States Illustrative Illustrative 34 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  35. 3.1 Market growth drivers (continued) 3.1.3 Philippines health spending, was $1180 Bn in 2021, an increase of 18.5% from $993 Bn in 2020 Fundings from government and other organizations Philippines has been experiencing steady growth in healthcare spending, which includes investments in infrastructure, facilities, and services ▪ Source Year Fund ($) This increasing funding has enabled the growth of dialysis facilities, the purchase of sophisticated technology, and the delivery of better dialysis services ▪ National Dialysis Institute (NCI) 2021 $ 6.4 Bn Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Centers for Disease Control and Prevention (CDC) 2021 $ 501 Mn In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ American Dialysis Society (ACS) Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2020 $ 150 Mn Susan G. Komen 2020 $ 98 Mn Illustrative Illustrative 35 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  36. 3.2 Market restraints 3.2.1 In 2020, the average cost of a new Dialysis drug was over $150,000 per year 3.2.2 Average cost of developing a new Dialysis drug that is ultimately approved by the FDA is over $2.6 Bn 3.2.3 Demand for Dialysis care is expected to increase by 42% by 2025, while the supply of oncologists is only expected to increase by 28% Dialysis treatments can be very expensive and can lead to financial burden for patients and healthcare systems Cost of Dialysis treatment varies depending on the type of Dialysis, stage of Dialysis, and treatment options Some common Dialysis treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars Regulatory requirements for Dialysis treatments can be very stringent, which can slow down the approval process and limit access to new treatments Regulatory bodies, such as Philippines Food and Drug Administration (FDA), require extensive clinical trials and safety data before approving new Dialysis treatments This can be a lengthy and costly process, which can delay the availability of new treatments for patients There is a shortage of oncologists in Philippines, which can limit access to Dialysis treatments and create barriers to growth in the Dialysis market Oncologists are physicians who specialize in the diagnosis and treatment of Dialysis With the aging population and the increasing incidence of Dialysis, there is a growing demand for oncologists However, the supply of oncologists is not keeping pace with the demand ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 36 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  37. Philippines Dialysis Market Analysis 4. Competitive Landscape

  38. 4.1 Major Market Share Revenue of Major players in Philippines Dialysis Market ($ Mn) Philippines Dialysis market is a highly competitive space, with many companies developing and marketing Dialysis treatments ▪ Other Some of the top companies in Philippines Dialysis market based on revenue and market share include ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ XX Illustrative Illustrative 38 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  39. 4.2 Key Company Profile Key Note: 1 Fresenius Medical Care Here is the list of top 10 companies which will cover in the final report ▪ 2 B. Braun Melsungen Each company will have slides for ▪ 3 Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report DaVita o o 4 Baxter Healthcare o o 5 Asahi Kasei Corporation o 6 o Nipro o 7 Nikkiso Medical Systems o 8 Angiodynamics ▪ 9 Hemotek Renal Center ▪ Nephro Group Dialysis Center 10 39 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  40. 4.2.1 Fresenius Medical Care Services offered by Fresenius Founded in: 1996 ▪ Fresenius Medical Care is a German healthcare firm that offers renal dialysis through a network of 4,171 outpatient dialysis facilities that serve 345,425 patients ▪ Fresenius Medical Care is the world's top provider of chronic renal failure services and products ▪ Fresenius Medical Care intends to strengthen its expertise and use it as a foundation for long-term, profitable growth ➢ Hemodialysis HQ: Bad Homberg, Germany ➢ Home Therapies Type: Private ➢ Critical Care Revenue: $19.40 Bn ➢ Pediatric Dialysis Website: www.fresenius.com ➢ Renal IT Solutions Recent Activity / Press Coverage Fresenius Medical Care sees improving trends in the first quarter and is progressing on its transformation 6008 CAREsystem FX CorAL Fresenius Medical Care charts path to unlock value as the leading kidney care company 5008 Paed Therapy System) Therapy Data Management System (TDMS) Fresenius Medical Care wins CIO 100 Award for novel tool to predict intradialytic hypotension) 40 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  41. 4.2.1 Fresenius Medical Care (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners One of the largest pharmaceutical distributors in the United States, McKesson has been a long-standing distribution partner for Fresenius Fresenius has been working with SAP, a leading software company, to develop digital solutions for its healthcare products A leading Swiss biotechnology company, Lonza provides Fresenius with contract manufacturing services for the production of its biologics and pharmaceuticals Cardinal Health is a Fortune 500 healthcare services company that provides pharmaceutical distribution services to Fresenius It is one of the largest drugstore chains in the United States and Europe, and its extensive network of retail locations and distribution centers make it an important distribution partner for Fresenius Fresenius has a strategic partnership with Microsoft to leverage its cloud computing and AI technologies in the development of new healthcare products Thermo Fisher Scientific is a leading provider of analytical instruments, reagents, and laboratory services A leading healthcare services provider in Asia, Zuellig Pharma is a distribution partner for Fresenius in several Asian countries GE Healthcare provides Fresenius with advanced medical imaging and diagnostics technologies, including CT scanners and MRI machines Illustrative Illustrative One of the largest pharmaceutical wholesalers in Europe, PHOENIX Group distributes Fresenius's products in several European countries 41 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  42. 4.2.1 Fresenius Medical Care (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers InterWell Health executed a three-way merger with Fresenius Health Partners and Cricket Health to become a renal care behemoth capable of managing $11 billion in expenses by 2025 Merger brings together Fresenius Health Partners' expertise in value-based kidney care contracting, InterWell Health's network of more than 1,600 nephrologists, and startup Cricket Health's technology-enabled care model and patient engagement platform ▪ Merger $2.4 Bn March, 2022 ▪ Interwell Health Fresenius to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 ▪ GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample ▪ Merger $1.8 Bn March 2021 GenMark Diagnostics GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the cause of infection and the most effective treatment, potentially saving lives and alleviating the healthcare burden ▪ Illustrative Illustrative 42 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  43. 4.2.1 Fresenius Medical Care (continued) Revenues ($Bn), 2020-2030 According to Fresenius's 2020 financial report, the company had sales of CHF 58.3 Bn (Swiss Francs) in 2020 ▪ This is equivalent to approximately $63.3 Bn USD, based on exchange rates at the end of 2020 ▪ XX Company's Pharmaceuticals Division generated sales of CHF 49.9 Bn in 2020, while the Diagnostics Division generated sales of CHF 8.4 Bn ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 Revenue generated by Fresenius in 2020 reflects the company's continued growth and success in the healthcare industry ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 43 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  44. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Dialysis Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 44 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  45. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 45 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  46. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 46 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  47. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 47 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  48. Philippines Dialysis Market Analysis 5. Reimbursement Scenario

  49. 5.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Americans The reimbursement scenario in the US Dialysis market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Medicare: o ▪ Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions Medicare covers many Dialysis treatments, including chemotherapy, radiation therapy, and some immunotherapies However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for Dialysis treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for Dialysis treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Other Public 1% o Other Private 3% Uninsured 9% Medicare 17% o ▪ Medicaid and CHIP 21% ▪ Employer-Sponsored 49% Health Insurance Coverage, 2022 Illustrative Illustrative 49 A Sample Report on Philippines Dialysis Market Analysis I Confidential

  50. 5.1 Reimbursement Regulation (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to Dialysis treatments by requiring insurers to cover certain preventive services, including Dialysis screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as Dialysis Reimbursement for New Treatments: Reimbursement for new Dialysis treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 50 A Sample Report on Philippines Dialysis Market Analysis I Confidential

More Related